Patent No. Europe EP 93100041.8 Granted EP/0550400 Austria EP 93100041.8 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Luxembourg EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 *United States 07/077,528
Appears in 2 contracts
Samples: License Agreement (OncoMed Pharmaceuticals Inc), License Agreement (OncoMed Pharmaceuticals Inc)
Patent No. Europe EP 93100041.8 86900983.7 Granted EP/0550400 EP/0211047 Austria EP 93100041.8 86900983.7 Granted EP/0550400 EP /0211047 Belgium EP 93100041.8 86900983.7 Granted EP/0550400 EP/0211047 France EP 93100041.8 86900983.7 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Luxembourg EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 *United States 07/077,528EP/0211047
Appears in 2 contracts
Samples: License Agreement (Affimed Therapeutics B.V.), License Agreement (Affimed Therapeutics B.V.)